CVE-2026-31070

Exploitation

Public exploit code exists. CISA's assessment records a public proof of concept. That is not a report of exploitation in the wild.

SSVC decision

• ExploitationpocPublic proof-of-concept exploit code exists. Not a report of exploitation in the wild.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.48% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 39.0% of scored records. A rank, not a probability.

NVD base score

9.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Deferred. NVD last modified this record on 2026-07-24.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2026-05-19 00:00Z3 MO AGO

Last updated

2026-05-20 13:55Z3 MO AGO

Reserved

2026-03-09

Assigning CNA

mitre

Record state

PUBLISHED

Severity

Critical (CVSS 9.8)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Weaknesses

• CWE-269Improper Privilege ManagementClass

Data version

5.2

Document digest

bd305bdccf0204a382bcebfbd2325c256cb691acbeed5046a491a9146367b67e

• github.comhttps://github.com/LalanaChami/Pharmacy-Mangment-System/blob/5c3d02888631166649856f71d542387114b3010b/backend/routes/user.js#L16
• gist.github.comhttps://gist.github.com/nedlir/22bf6d1a3a07209be3e343744bc81d51